Material Group inc. Logo

Material Group inc.

A professional services firm offering PR consulting, marketing, and brand strategy.

156A | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区赤坂一丁目12番32号アーク森ビル35階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Material Group Inc. is a professional services firm that offers comprehensive marketing and communications support, with a core focus on PR consulting. The company operates as a collective of specialized businesses that collaborate to provide tailored solutions for a diverse range of clients. Its services include brand strategy analysis, market research, and business marketing, all aimed at maximizing the potential of clients' brands, products, and services. In March 2024, Material Group was listed on the Tokyo Stock Exchange's Growth Market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-09 08:39
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.7 KB
2025-05-15 10:10
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.3 KB
2025-04-14 08:31
Regulatory News Service
確認書
Japanese 8.1 KB
2025-04-14 08:30
Interim Report
半期報告書-第12期(2024/09/01-2025/08/31)
Japanese 197.5 KB
2024-12-02 07:32
Regulatory News Service
訂正臨時報告書
Japanese 32.7 KB
2024-11-28 07:32
Post-Annual General Meeting Information
臨時報告書
Japanese 23.1 KB
2024-11-28 07:31
Governance Information
内部統制報告書-第11期(2023/09/01-2024/08/31)
Japanese 23.6 KB
2024-11-28 07:31
Registration Form
確認書
Japanese 8.1 KB
2024-11-28 07:30
Annual Report
有価証券報告書-第11期(2023/09/01-2024/08/31)
Japanese 1.9 MB
2024-11-27 07:30
Earnings Release
臨時報告書
Japanese 18.4 KB
2024-07-12 08:01
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:01
Quarterly Report
四半期報告書-第11期第3四半期(2024/03/01-2024/05/31)
Japanese 144.7 KB
2024-04-30 08:14
Major Shareholding Notification
臨時報告書
Japanese 20.3 KB
2024-04-12 08:03
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-04-12 08:02
Quarterly Report
四半期報告書-第11期第2四半期(2023/12/01-2024/02/29)
Japanese 168.5 KB

Automate Your Workflow. Get a real-time feed of all Material Group inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Material Group inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hybrigenics SA Logo
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France ALHYG
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
Immunic AG Logo
Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.
United States of America IMUX
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan 6535
INBIOGEN CO.,Ltd Logo
Data mining, bioinformatics, and virtual assistance for the life sciences industry.
South Korea 101140
Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea 216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan 7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France IPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.